Research suggests that Phellodendron, primarily through its active compound berberine, may support stress relief by modulating the hypothalamic-pituitary-adrenal (HPA) axis, reducing corticosterone markers, and influencing neurotransmitter activity relevant to mood and stress response. Studies indicate anxiolytic and antidepressant-like effects in preclinical models, with several reviews also noting anti-inflammatory actions from phellodendrine, another constituent of the plant's bark. The available evidence consists largely of reviews and preclinical animal studies rather than randomized controlled trials in humans, which represents a meaningful limitation in drawing firm conclusions about efficacy in people. While the direction of findings is consistently supportive, the gap between animal and human evidence means that how well these mechanisms translate to real-world stress relief in humans remains an open question.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Research progress on antidepressant effects and mechanisms of berberine. | Review | 2024 | Supports | 82 |
| Berberine exerts antidepressant effects in vivo and in vitro through the PI3K... | Other | 2024 | Supports | 78 |
| Pharmacological effects of berberine on mood disorders. | Review | 2019 | Supports | 72 |
| Current Evidence and Future Directions of Berberine Intervention in Depression. | Review | 2022 | Supports | 70 |
| Biological Importance of Phellodendrine in Traditional and Modern Medicines: ... | Review | 2024 | Supports | 65 |